Discover how innovations in technology are transforming data into assets. Jupiter, FL—In a new episode scheduled for 4Q/2020, the award-winning series, Advancements with Ted Danson, will focus on breakthroughs in clinical services and solutions. With a focus on EDETEK, Inc. (EDETEK) –an innovative clinical solutions company that provides high-quality technology platforms and related clinical services to pharmaceutical, biotechnology, and medical device companies– viewers will learn how the company transforms data into assets via its innovative solutions. The show will explore EDETEK’s clinical platform, CONFORM™, and will educate audiences on its ability to successfully address some of the most challenging aspects
Modern clinical technology helps scientists to accelerate the development of new therapies and vaccines PRINCETON, New Jersey, July 14, 2020 – EDETEK, the premier provider of digital clinical trial computer systems, today announced that the company’s cloud-based eClinical and clinical informatics platforms CONFORM™ are supporting multiple clinicals sponsors in research and development of emergent COVID-19 treatments and vaccines. Jian Chen, EDETEK’s President and CEO, “Our customers use CONFORM ™ in Phase I, II and III COVID-19 clinical trials. In some trials our Platform is used entirely as an end to end clinical system. Customers also implemented selective CONFORM™ components to add
Pfizer, EDETEK, and PatientLink are excited to reveal a new approach to clinical research that enables real-time, 360-degree patient engagement and data sharing between patients, sites and researchers to improve clinical research and data return through eSource.
What comes first: digital health innovation or regulatory policy? Disruptive innovations are abounding in clinical research with virtual remote clinical trials, big data and the call for standardization of data in translational and clinical research. More info: https://www.himsslearn.org/breaking-barriers-road-ahead-pharma-and-clinical-research